Obesity treatment has entered a new era with innovative medications offering transformative results. Yet, a troubling reality persists: many who need these life-changing treatments most face the ...

New research presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) shows that, following ...

Joseph Zucchi, PA-C Obesity is a chronic disease, but we aren’t treating it like one. Right now in Massachusetts, state employees covered through the Group Insurance Commission are set to lose ...

Children who respond well to pediatric obesity treatment have markedly lower morbidity and mortality risks in young adulthood, according to data published on January 21 in JAMA Pediatrics. Researchers ...

OBSCORE is a data-driven tool that identifies high-risk individuals for obesity-related diseases, enhancing treatment ...

Please provide your email address to receive an email when new articles are posted on . Treat obesity as the root cause of diabetes. By integrating obesity care into diabetes prevention programs, ...

About a third of us in Missouri and Kansas are obese, but getting a prescription for one of these powerful drugs online comes ...

Amgen stock toppled Friday as investors digested its "generally in-line" first-quarter report and expansion in the obesity treatment space.

The market for obesity treatment is expected to expand more than fifteenfold by 2030 due to escalating competition, fueled by clinical data not only from Novo Nordisk and Eli Lilly but also from other ...

When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as they reach young ...

People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and ...